Air Mobility Command Public Affairs
3/4/2015 - SCOTT AIR FORCE BASE, Illinois -- A
recent Joint Capability Technology Demonstration on a C-130 cargo
aircraft at Orlando International Airport, Florida, showed how hot,
humid air can decontaminate large pieces of equipment from biological
The Air Mobility Command-hosted final out-brief and demonstration of the
Joint Biological Agent Decontamination System on Jan. 22 signaled the
multi-year project is coming to a close. The success of the new
technology is the result of collaboration among several Department of
Defense and other government organizations.
During the demonstration, an Air Force Research Laboratory technical
team simulated Anthrax contamination by using an environmentally safe,
commercially available organic insecticide. The team, with contract
support from AeroClave LLC, then showed how heat and humidity in a
closed environment can eliminate both interior and exterior biological
"Although final results of the JCTD are pending, preliminary indicators
point to a 'complete kill' of the biological simulant," said Larry
Magnuson, AMC JBADS Operational Manager.
JBADS is a revolutionary decontamination process designed to meet an
urgent joint service need to expedite the return of a biologically
contaminated aircraft to full service without placing aircrew members
and support personnel at risk of exposure. U.S. Transportation Command
and U.S. Strategic Command sponsored, and AMC managed, the JBADS JCTD.
In the final Operational Utility Assessment November 2014 through
January 2015, AFRL conducted two separate JBADS demonstrations using
high levels of heat and relative humidity (170 degrees Fahrenheit and 90
percent relative humidity). The two decontamination cycles ran three
and four days, respectively, to complete. The goal of each demonstration
was to reduce simulant concentrations to "below infectious levels."
An additional goal was to ensure that the JBADS process was not harmful
to aircraft equipment and material. An independent assessment is still
under way to confirm the findings; however, the preliminary results
indicate that all JBADS goals were met. The final assessment report is
expected by April.
Dr. Donald Erbschloe, Air Mobility Command Chief Scientist, hosted the
JBADS JCTD final outbrief that was attended by the Air Force Chief
Scientist as well as representatives of the Office of the Assistant
Secretary of Defense for Research & Engineering (Emerging
Capabilities & Prototyping), Department of Homeland Security, Joint
Requirements Office, Joint Science and Technology Office, Joint Program
Executive Office, USTRANSCOM, U.S. Strategic Command, Defense Threat
Reduction Agency, Headquarters U.S. Air Force, Air Force Special
Operations Command and AMC.
Erbschloe said, "This series of JBADS demonstrations culminates a
seven-year effort to find a process that will neutralize biological
warfare agents and naturally-occurring diseases such as pandemic
influenza and Ebola without harming aircraft systems and ensuring the
safety of aircrew, maintainers, and ground handlers."
He said the results look promising. "The success of the demonstration
would not have been possible without the outstanding research and
support provided by a large cross section of DOD agencies and industry
working in full cooperation. This was a true team effort. This was a
true team effort."
With the completion of the JBADS demonstrations, the results will be
forwarded for future development while the aircraft and the associated
equipment remain available for future DOD studies and deployment if